Insider filing · BBIO
Andrew Lo
Director
profile →
BridgeBio Pharma, Inc.
BBIO · Healthcare · 74 filings in 24 months
ticker →
Andrew Lo sold $3.9M of BridgeBio Pharma (BBIO)
Executed May 2 2025, disclosed May 6 2025, 4 days later.
Value, as filed
$3.9M
100,000 sh × $38.50
Executed
May 2 2025
the trade date, as filed
Disclosed
May 6 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
ALAndrew Lo (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $6.3M of BBIO (95,599 sh across 4 lots, as filed), executed Nov 17 2025.
The name
BBIOHealthcare · BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Andrew Lo in BBIO
BBIOSALE
BridgeBio Pharma, Inc.
$6.3M95,599 sh across 4 lots
Exec Nov 17 2025
Filed Nov 19 2025 · 5:30 PM ET